Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Seegene, a biotechnology company, has introduced the Seeplex Diarrhea ACE detection test that provides a novel and fast-acting multiplex polymerase chain reaction diagnostic technique to simultaneously verify a complex range of pathogens that cause diarrhea.
Subscribe to our email newsletter
Based on the company’s dual priming oligo (DPO) technology, the Seeplex diarrhea ACE detection tests for 10 bacteria (Salmonella species, Shigella species, Campylobacter species, Vibrio species, C difficile Toxin B, C perfringens, Y enterocolitica, Aeromonas species, E.coli0157:H7, Verocytotoxin-producing E.coli) and four viruses (rotavirus, norovirus, enteric adenovirus, astrovirus) that cause diarrhea.
By accurately detecting and differentiating diarrhea causing viruses from bacteria, the Seeplex diarrhea ACE detection test will help healthcare practitioners apply the correct course of treatment for patients at the earliest possible stage, the company said.
Jong-Yoon Chun, founder and CEO of Seegene, said: “Taking only six hours to detect either bacterial or viral infection, Seeplex diarrhea ACE detection is an accurate, rapid and cost-effective diarrhea diagnostic tool that offers a new way for diagnosing diarrhea.”